Characteristics of cranial vault lymphoma from a systematic review of the literature.
Calvarial lymphoma
Calvarium
Lymphosarcoma
Reticulum cell sarcoma
Skull
Journal
Surgical neurology international
ISSN: 2229-5097
Titre abrégé: Surg Neurol Int
Pays: United States
ID NLM: 101535836
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
01
2022
accepted:
06
05
2022
entrez:
20
7
2022
pubmed:
21
7
2022
medline:
21
7
2022
Statut:
epublish
Résumé
Cranial vault lymphomas are rare and their clinical features are often similar to those of cranial vault meningiomas. The objective of this review was to identify the features helpful for differentiating lymphomas of the cranial vault, from meningiomas which were the most common diagnosis before the definitive pathological diagnosis. The inclusion criterion was a histologically proven malignant lymphoma initially appearing in the calvarium. We conducted a literature search of the electronic PubMed and Ichushi-Web databases up to June 1, 2020. Cranial vault lymphoma that was diagnosed after an original diagnosis of lymphoma in a nodal or soft-tissue site was excluded from the study. Descriptive analyses were used to present the patient characteristics. A total of 111 patients were found in 98 eligible articles. Almost all studies were case reports. The most common symptom was a growing subcutaneous scalp mass (84%) present for a mean duration of 5.9 months before the patient presented for treatment in analyzable cases; this fast growth may distinguish lymphomas from meningiomas. The tumor vascularization was often inconspicuous or poor, unlike well-vascularized meningiomas. A disproportionately small amount of skull destruction compared with the soft-tissue mass was observed in two-thirds of the analyzable cases. This qualitative systematic review identified several features of cranial vault lymphomas that may be useful in differentiating them from meningiomas, including a rapidly growing subcutaneous scalp mass, poor vascularization, and limited skull destruction relative to the size of the soft-tissue mass.
Sections du résumé
Background
UNASSIGNED
Cranial vault lymphomas are rare and their clinical features are often similar to those of cranial vault meningiomas. The objective of this review was to identify the features helpful for differentiating lymphomas of the cranial vault, from meningiomas which were the most common diagnosis before the definitive pathological diagnosis.
Methods
UNASSIGNED
The inclusion criterion was a histologically proven malignant lymphoma initially appearing in the calvarium. We conducted a literature search of the electronic PubMed and Ichushi-Web databases up to June 1, 2020. Cranial vault lymphoma that was diagnosed after an original diagnosis of lymphoma in a nodal or soft-tissue site was excluded from the study. Descriptive analyses were used to present the patient characteristics.
Results
UNASSIGNED
A total of 111 patients were found in 98 eligible articles. Almost all studies were case reports. The most common symptom was a growing subcutaneous scalp mass (84%) present for a mean duration of 5.9 months before the patient presented for treatment in analyzable cases; this fast growth may distinguish lymphomas from meningiomas. The tumor vascularization was often inconspicuous or poor, unlike well-vascularized meningiomas. A disproportionately small amount of skull destruction compared with the soft-tissue mass was observed in two-thirds of the analyzable cases.
Conclusion
UNASSIGNED
This qualitative systematic review identified several features of cranial vault lymphomas that may be useful in differentiating them from meningiomas, including a rapidly growing subcutaneous scalp mass, poor vascularization, and limited skull destruction relative to the size of the soft-tissue mass.
Identifiants
pubmed: 35855149
doi: 10.25259/SNI_28_2022
pii: 10.25259/SNI_28_2022
pmc: PMC9282819
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
231Informations de copyright
Copyright: © 2022 Surgical Neurology International.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Pak Med Assoc. 2020 Apr;70(4):767-768
pubmed: 32296234
Br J Neurosurg. 2018 Apr;32(2):214-215
pubmed: 27619411
Neurochirurgie. 1993;39(1):50-3
pubmed: 8377886
Pan Afr Med J. 2011;8:50
pubmed: 22121457
No Shinkei Geka. 1991 Mar;19(3):279-83
pubmed: 2038420
No Shinkei Geka. 1993 Nov;21(11):1061-4
pubmed: 8255384
Rev Neurol. 2011 Dec 16;53(12):735-8
pubmed: 22127660
J Clin Oncol. 2006 Sep 20;24(27):4521-2
pubmed: 16983124
Neurosurg Rev. 1998;21(2-3):202-5
pubmed: 9795963
J Craniofac Surg. 2015 Sep;26(6):e492-4
pubmed: 26221858
Wien Med Wochenschr. 1949 Jan 1;99(1-2):12
pubmed: 18111154
J Acquir Immune Defic Syndr (1988). 1994 Jun;7(6):629-30
pubmed: 8176647
BMJ Case Rep. 2016 Feb 22;2016:
pubmed: 26903363
Neurochirurgia (Stuttg). 1983 Jul;26(4):130-2
pubmed: 6621766
Neurol India. 2013 Mar-Apr;61(2):201-4
pubmed: 23644340
AJNR Am J Neuroradiol. 2003 Aug;24(7):1324-6
pubmed: 12917120
Med J Malaysia. 1997 Mar;52(1):86-8
pubmed: 10968060
Skeletal Radiol. 2019 Jun;48(6):897-905
pubmed: 30310943
No Shinkei Geka. 2003 Jan;31(1):43-7
pubmed: 12533904
Brain Tumor Res Treat. 2013 Apr;1(1):32-5
pubmed: 24904887
Cancer. 1986 Dec 15;58(12):2646-55
pubmed: 3779614
J Neurosurg. 2008 May;108(5):1018-20
pubmed: 18447722
Neurol India. 2003 Jun;51(2):293-4
pubmed: 14571046
Del Med J. 1959 Oct;31:306-9
pubmed: 14432792
Haematologica. 2004 Apr;89(4):EIM06
pubmed: 15075109
Asian J Neurosurg. 2016 Oct-Dec;11(4):444
pubmed: 27695553
Neuroradiology. 1995 Aug;37(6):456-8
pubmed: 7477857
Oncol Lett. 2016 Jun;11(6):3583-3588
pubmed: 27284359
Hum Pathol. 2017 Feb;60:1-10
pubmed: 27554207
Br J Neurosurg. 2007 Dec;21(6):629-30
pubmed: 18071996
Surg Neurol. 1994 Aug;42(2):117-20
pubmed: 8091287
Neurol India. 2013 May-Jun;61(3):334-6
pubmed: 23860174
JBR-BTR. 2010 Nov-Dec;93(6):296-8
pubmed: 21381526
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
Indian J Cancer. 2007 Jan-Mar;44(1):36-7
pubmed: 17401223
Br J Neurosurg. 2012 Oct;26(5):756-8
pubmed: 22463812
Neurology. 2009 Oct 27;73(17):e84-5
pubmed: 19858452
Surg Neurol. 1993 Apr;39(4):286-9
pubmed: 8488447
Neuroradiology. 1996 Apr;38(3):211-3
pubmed: 8741188
Rev Neurol (Paris). 2017 Dec;173(10):668-670
pubmed: 28629635
Neurology. 1989 Sep;39(9):1190-6
pubmed: 2788832
Clin Radiol. 2002 Oct;57(10):948-50
pubmed: 12413922
Med J Aust. 1973 Mar 10;1(10):499-500
pubmed: 4573378
Zentralbl Neurochir. 2006 Feb;67(1):26-9
pubmed: 16518748
Rinsho Ketsueki. 1987 Apr;28(4):589-93
pubmed: 3498053
J Neurosurg. 1976 Dec;45(6):712-5
pubmed: 978244
J Neurooncol. 2016 Jan;126(1):209-211
pubmed: 26456022
Brain Tumor Pathol. 2015 Oct;32(4):275-80
pubmed: 26177806
J UOEH. 2019;41(3):335-342
pubmed: 31548488
Acta Neurochir (Wien). 2007 Jun;149(6):601-4
pubmed: 17460815
J Neurooncol. 2010 Oct;100(1):9-15
pubmed: 20146083
Br J Neurosurg. 2004 Oct;18(5):518-23
pubmed: 15799158
Neurol Med Chir (Tokyo). 2010;50(7):595-8
pubmed: 20671390
No Shinkei Geka. 1985 Nov;13(11):1191-6
pubmed: 4088441
Br J Neurosurg. 1997 Oct;11(5):433-6
pubmed: 9474277
Eur Radiol. 2001;11(8):1506-9
pubmed: 11519566
Ann Oncol. 2007 Jan;18(1):129-135
pubmed: 17018705
Blood. 1987 Sep;70(3):624-8
pubmed: 3113511
No Shinkei Geka. 2003 Apr;31(4):419-24
pubmed: 12704823
J Comput Assist Tomogr. 1985 Jul-Aug;9(4):725-7
pubmed: 3894439
Int J Hematol. 2017 Aug;106(2):147-148
pubmed: 28390034
Neurochirurgie. 1995;41(5):329-36
pubmed: 8577352
Clin Imaging. 2003 Nov-Dec;27(6):386-8
pubmed: 14585564
Acta Neurochir (Wien). 2000;142(5):597-8
pubmed: 10898370
J Eur Acad Dermatol Venereol. 2016 Jan;30(1):186-7
pubmed: 25174371
Pediatr Dev Pathol. 2001 Jul-Aug;4(4):397-401
pubmed: 11441342
An Med Interna. 1999 Apr;16(4):186-8
pubmed: 10339844
Acta Oncol. 2008;47(2):326-9
pubmed: 17851874
J Neurol Neurosurg Psychiatry. 1994 Jun;57(6):751-4
pubmed: 8006662
Semin Roentgenol. 1974 Jul;9(3):229-40
pubmed: 4601850
Cancer. 1969 Sep;24(3):569-73
pubmed: 4898827
J Neurosurg Sci. 1987 Oct-Dec;31(4):183-6
pubmed: 3454361
Acta Neurochir (Wien). 2012 Feb;154(2):257-65; discussion 265
pubmed: 21842209
Neurosurgery. 1991 Dec;29(6):898-901
pubmed: 1758604
Cancer. 1986 Jul 15;58(2):318-20
pubmed: 3719524
Acta Haematol. 2005;113(4):258-61
pubmed: 15983433
J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):769
pubmed: 17575023
Eur J Radiol. 1994 Nov;19(1):7-9
pubmed: 7859766
Neurosurg Focus. 2006 Nov 15;21(5):E10
pubmed: 17134112
Clin Oncol (R Coll Radiol). 1997;9(3):195-6
pubmed: 9269557
Neurochirurgie. 2002 May;48(2-3 Pt 1):124-7
pubmed: 12053171
CA Cancer J Clin. 2020 Jan;70(1):47-70
pubmed: 31815293
Pediatr Radiol. 1995 Nov;25 Suppl 1:S232-3
pubmed: 8577538
J Clin Neurosci. 2014 Feb;21(2):351-3
pubmed: 24094361
Int J Surg Pathol. 2020 May;28(3):330-335
pubmed: 31631721
JBR-BTR. 2005 May-Jun;88(3):152-3
pubmed: 16038238
Rinsho Ketsueki. 1991 May;32(5):537-41
pubmed: 1870271
Medicine (Baltimore). 2019 Feb;98(7):e14465
pubmed: 30762761
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4381-90
pubmed: 25120823
Am J Roentgenol Radium Ther Nucl Med. 1954 Jan;71(1):40-50
pubmed: 13114508
Case Rep Neurol Med. 2012;2012:616813
pubmed: 22937355
Cancer. 1987 Jan 15;59(2):335-9
pubmed: 3802019
J Clin Exp Hematop. 2013;53(3):215-9
pubmed: 24369223
Neurochirurgie. 1994;40(6):369-71
pubmed: 7596458
Acta Neurochir (Wien). 2008 May;150(5):507-8; discussion 508
pubmed: 18297234
Am J Med. 2013 Oct;126(10):e7-8
pubmed: 23910518
Am J Roentgenol Radium Ther Nucl Med. 1958 Apr;79(4):653-7
pubmed: 13521117
Ann Hematol. 2000 Dec;79(12):700-2
pubmed: 11195009
Ann Hematol. 2018 Jan;97(1):183-184
pubmed: 28868592
Radiol Case Rep. 2018 Apr 16;13(3):658-662
pubmed: 30046364
Cancer Radiother. 2016 Dec;20(8):811-814
pubmed: 27793530
Iran J Radiol. 2012 Jun;9(2):88-92
pubmed: 23329970
J Mt Sinai Hosp N Y. 1964 May-Jun;31:241-4
pubmed: 14167684
Cancer. 1995 Oct 1;76(7):1261-7
pubmed: 8630907